Enhanced oral bioavailability of oleanolic acid in rats with phospholipid complex

Letters in Drug Design and Discovery

Volumn 9, Issue 5, 2012, Pages 505-512

  Cao, Feng ^a   Gao, Yahan ^a   Yin, Zhi ^a   Ping, Qineng ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

HPLC MS MS; Oleanolic acid; Oral bioavailability; Pharmacokinetics; Phospholipid complex

Indexed keywords

OCTANOL; OLEANOLIC ACID; OLEANOLIC ACID PHOSPHOLIPID COMPLEX; PHOSPHOLIPID; UNCLASSIFIED DRUG; WATER;

AQUEOUS SOLUTION; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFRARED SPECTROSCOPY; MALE; MASS SPECTROMETRY; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; X RAY POWDER DIFFRACTION;

EID: 84860746035     PISSN: 15701808     EISSN: 1875628X     Source Type: Journal    
DOI: 10.2174/157018012800389340     Document Type: Article

References (33)

1. Liu, J. Oleanolic acid and ursolic acid: research perspectives. J. Ethnopharmacol., 2005, 100, 92-94. (Pubitemid 41073528)
2. Giner-Larza, E.M.; Máñez, S.; Recio, M.C.; Giner, R.M.; Prieto, J.M.; Cerdá-Nicolás, M.; Ríos, J.L. Oleanolic acid, a 3- oxotriterpene from Pistascia, inhibits leukotriene synthesis and has anti-inflammatory activity. Eur. J. Pharmacl., 2001, 428, 137-143. (Pubitemid 32971767)
3. Maia, J.L.; Lima-Júnior, R.C.; David, J.P.; David, J.M.; Santos, F.A.; Rao, V.S. Oleanolic acid, a pentacyclic triterpene attenuates the mustard oil-induced colonic nociception in mice. Biol. Pharm. Bull., 2006, 29, 82-85. (Pubitemid 43036699)
4. Hsu, H.Y.; Yang, J.J.; Lin, C.C. Effects of oleanolic acid and ursolic acid on inhibiting tumor growth and enhancing the recovery of hematopoietic system postirradiation in mice. Cancer Lett., 1997, 111, 7-13.
5. Cheung, H.Y.; Zhang, Q.F. Enhanced analysis of triterpenes, flavonoids and phenolic compounds in Prunella vulgaris L. by capillary zone electrophoresis with the addition of running buffer modifiers. J. Chromatogr. A., 2008, 1213, 231-238.
6. Jeong, D.W.; Kim, Y.H.; Kim, H.H.; Ji, H.Y.; Yoo, S.D.; Choi, W.R.; Lee, S.M.; Han, C.K.; Lee, H.S. Dose-linear pharmacokinetics of oleanolic acid after intravenous and oral administration in rats. Biopharm. Drug Dispo., 2007, 28, 51-57. (Pubitemid 46455766)
7. Amidon, G.L.; Lennernäs, H.; Shah, V.P.; Crison, J.R. A theoretical basis for a biopharmaceutics drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res., 1995, 12, 413-420.
8. Guidance for Industry: Waiver of in vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System. Food and Drug Administration, United States, Rockville, 2000.
9. Chen, Y.; Liu, J.; Yang, X.; Zhao, X.; Xu, H. Oleanolic acid nanosuspensions: preparation, in-vitro characterization and enhanced hepatoprotective effect. J. Pharm. Pharmacol., 2005, 57, 259-264. (Pubitemid 40129096)
10. Xi, J.; Chang, Q.; Chan, C.K.; Meng, Z.Y.; Wang, G.N.; Sun, J.B.; Wang, Y.T.; Tong, H.H.; Zheng, Y. Formulation development and bioavailability evaluation of a self-nanoemulsified drug delivery system of oleanolic acid. AAPS Pharm. Sci. Tech., 2009, 10, 172-182.
11. Tong, H.H.; Du, Z.; Wang, G.N.; Chan, H.M.; Chang, Q.; Lai, L.C.; Chow, A.H.; Zheng, Y. Spray freeze drying with polyvinylpyrrolidone and sodium caprate for improved dissolution and oral bioavailability of oleanolic acid, a BCS Class IV compound. Int. J. Pharm., 2011, 404, 148-158.
12. Semalty, A.; Semalty, M.; Rawat, B.S.; Singh, D.; Rawat, M.S. Pharmacosomes: the lipid-based new drug delivery system. Expert Opin. Drug Deliv., 2009, 6, 599-612.
13. Qin, X.; Yang, Y.; Fan, T.T.; Gong, T.;, Zhang, X.N.; Huang, Y. Preparation, characterization and in vivo evaluation of bergeninphospholipid complex. Acta. Pharmacol. Sin., 2010, 31, 127-136.
14. Gupta, N.K.; Dixit, V.K. Bioavailability enhancement of curcumin by complexation with phosphatidyl choline. J. Pharm. Sci., 2011, 100, 1987-1995.
15. Sharma, A.; Gupta, N.K.; Dixit, V.K. Complexation with phosphatidyl choline as a strategy for absorption enhancement of boswellic acid. Drug Deliv., 2010, 17, 587-595.
16. Wu, Z.H.; Zhou, J.; Ping Q.N.; Zhang Y.H.; Wang Z.L.; Zhou, H. Transport of indirubin phytosomes across the membrane and its pharmacokinetics in Beagle dogs. J. china pharma. univer., 2007; 38, 327-331. (Pubitemid 47214964)
17. Wang, S.; Sun, M.; Ping, Q. Enhancing effect of Labrafac Lipophile WL 1349 on oral bioavailability of hydroxysafflor yellow A in rats. Int. J. Pharm., 2008, 358, 198-204.
18. Song, Y.; Zhuang, J.; Guo, J.; Xiao, Y.; Ping, Q. Preparation and properties of a silybin-phospholipid complex. Pharmazie , 2008, 63, 35-42. (Pubitemid 351155202)
19. Xiao, Y.Y.; Song, Y.M.; Cheng Z.P.; Ping, Q.N. The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats. Int. J. Pharm., 2006, 307, 77-82.
20. Wu, Z.; Guo, D.; Deng, L. ; Zhang, Y.; Yang, Q.; Chen, J. Preparation and evaluation of a self-emulsifying drug delivery system of etoposide-phospholipid complex. Drug Dev. Ind. Pharm., 2011, 37, 103-112.
21. Zhang, Z.; Huang, Y.; Gao, F.; Bu, H.; Gu, W.; Li, Y. Daidzeinphospholipid complex loaded lipid nanocarriers improved oral absorption: in vitro characteristics and in vivo behavior in rats. Nanoscale, 2011, 3, 1780-1787.
22. Yue, P.F.; Yuan, H.L.; Xie, H.; Xiao, X.H.; Yang, M.; Liao, M.X.; Zhu, W.F.; Cai, P.L. Preparation, characterization, and bioavailability of ursodeoxycholic acid-phospholipid complex in vivo. Drug Dev. Ind. Pharm., 2008, 34, 708-718. (Pubitemid 351965485)
23. Yang, R. ; Su, L.Q.; Huang, X.; Zhai, G.X. Preparation and in Vitro Dissolution of Oleanolic Acid Self- Microemulsifying Drug Delivery System. China Pharm., 2010, 21, 3128-3130.
24. Song, M.; Hang, T.J.; Wang, Y.; Jiang, L.; Wu, X.L.; Zhang, Z.; Shen, J.; Zhang, Y. Determination of oleanolic acid in human plasma and study of its pharmacokinetics in Chinese healthy male volunteers by HPLC tandem mass spectrometry. J. Pharm. Biomed. Anal., 2006, 40, 190-196. (Pubitemid 43061237)
25. Lasonder, E.; Weringa, W.D. An NMR and DSC study of the interaction of phospholipids vesicles with some anti-inflammatory agents. J. Colloid. Interface Sci., 1990, 139, 469-478.
26. Li, Y.; Yang, D.J.; Chen, S.L.; Chen, S.B.; Chan, A.S.. Comparative physicochemical characterization of phospholipids complex of puerarin formulated by conventional and supercritical methods. Pharm. Res., 2008, 25, 563-577. (Pubitemid 351357731)
27. Xu, X.D.; Sun, H.H.; Rong, R.; Wen, B.; Zhang, X.R.; He, Z.G. Pharmacokinetics and relative bioavailability of compound oleanolic acid soft capsules in rats. Chinese J. Pharm., 2008; 6: 392-399.
28. Mukherjee, P.K. Problems and prospects for the GMP in herbal drugs in Indian Systems of Medicine. Drug Inf. J., 2002; 63, 6635-6644.
29. Semalty, A.; Semalty, M.; Rawat, M.S.; Franceschi, F. Supramolecular phospholipids-polyphenolics interactions: the PHYTOSOME strategy to improve the bioavailability of phytochemicals. Fitoterapia, 2010, 81, 306-314.
30. Venema, F.R.; Weringa, W.D. The interactions of phospholipid vesicles with some anti-inflammatory agents. J. Colloid. Interface Sci., 1988, 125, 484-500.
31. Hüsch, J.; Dutagaci, B.; Glaubitz, C.; Geppert, T.; Schneider, G.; Harms, M.; Müller-Goymann, C.C.; Fink, L.; Schmidt, M.U.; Setzer, C.; Zirkel, J.; Rebmann, H.; Schubert-Zsilavecz, M.; Abdel- Tawab, M. Structural properties of so-called NSAID-phospholipidcomplexes. Eur. J. Pharm. Sci., 2011, 44, 103-116.
32. Chen, Z.P.; Sun, J.; Chen, H.X.; Xiao, Y.Y.; Liu, D.; Chen, J.; Cai, H.; Cai, B.C. Comparative pharmacokinetics and bioavailability studies of quercetin, kaempferol and isorhamnetin after oral administration of Ginkgo biloba extracts, Ginkgo biloba extract phospholipid complexes and Ginkgo biloba extract solid dispersions in rats. Fitoterapia, 2010, 81, 1045-1052.
33. Huang, S.L.; Ling, P.X.; Zhang, T.M. Oral absorption of hyaluronic acid and phospholipids complexes in rats. World J. Gastroenterol., 2007, 13, 945-949.